Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
29 studies found for:    " July 06, 2011":" August 05, 2011"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Download search resultsDownload the search results for:
" July 06, 2011":" August 05, 2011"[FIRST-RECEIVED-DATE]AND HIV[CONDITION] (29 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Completed Connect to Protect (C2P): Building a Community-Based Infrastructure for HIV Prevention
Condition: HIV Infection
Intervention: Behavioral: Community Mobilization
2 Completed Safety and Immunogenicity Study of a DNA Priming and MVA Boosting Strategy of HIV Vaccine
Condition: HIV Infections
Interventions: Biological: DNA HIVIS and MVA-CMDR;   Biological: Saline solution
3 Completed Physiologic Investigation of the Renin Angiotensin Aldosterone Axis in HIV
Condition: HIV-infection
Intervention: Drug: Angiotensin II Infusion
4 Completed Post-marketing Safety Surveillance Program in Human Immunodeficiency Virus (HIV)-Infected Children Exposed to Atazanavir in Europe
Condition: HIV Infection
Intervention:
5 Active, not recruiting Effectiveness of Peer Navigation to Link Released HIV+ Jail Inmates to HIV Care
Condition: HIV-infection/Aids
Intervention: Behavioral: Health Navigator
6 Withdrawn Impact of Menstrual Cycle on Antiretroviral Pharmacokinetics in HIV-Infected Women
Condition: HIV Infected
Intervention: Drug: Tenofovir, Emtricitabine, Atazanavir, Ritonavir
7 Recruiting Characteristics of Immune Cells in Gut Mucosa of HIV Negative and HIV Positive Thais
Condition: HIV-infection
Intervention: Procedure: Colon biopsy, lymph node biopsy, lumbar puncture
8 Unknown  Depression and ART Adherence in HIV+ Latinos
Conditions: Depressive Symptoms;   HIV Infections
Intervention: Behavioral: Cognitive-Behavioral Therapy AD
9 Completed Centralized Off-Site Adherence Enhancement Program
Condition: HIV/AIDS, Medication Adherence
Intervention: Behavioral: cognitive-behavioral therapy
10 Terminated Prevention of Early Mortality by Presumptive Tuberculosis (TB) Treatment
Conditions: HIV Infection;   Tuberculosis
Interventions: Drug: Experimental: Empiric TB treatment;   Drug: ART only arm
11 Completed Discontinuation of Primary and Secondary Prophylaxis for Opportunistic Infections in HIV-infected Patients
Condition: HIV Infection
Intervention: Other: Discontinuation of prophylactic drugs i.e. co-trimoxazole, dapsone, fluconazole, itraconazole, azithromycin
12 Completed A Safety Study Of A Single Vaginal Administration Of P2G12 Antibody In Healthy Female Subjects
Condition: Human Immunodeficiency Virus
Intervention: Drug: P2G12
13 Completed Moringa Oleifera- Antiretroviral Pharmacokinetic Drug Interaction
Condition: HIV
Intervention: Dietary Supplement: Moringa oleifera
14 Active, not recruiting Eplerenone in HIV Associated Abdominal Fat Accumulation
Condition: HIV
Interventions: Drug: Eplerenone and lifestyle;   Other: placebo and lifestyle
15 Completed
Has Results
Taste Assessment Study of 2 Atazanavir Powder Formulations in Healthy Subjects
Condition: HIV
Interventions: Drug: Atazanavir (current formulation);   Drug: Atazanavir, powder for oral use 1 (POU1);   Drug: Atazanavir (POU2)
16 Active, not recruiting Stanford Universities: The Stanford HIV Aging Cohort
Condition: Acquired Immunodeficiency Syndrome
Intervention:
17 Active, not recruiting Adolescent Master Protocol
Condition: HIV/AIDS
Intervention:
18 Active, not recruiting Evaluating the Safety and Effectiveness of Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Conditions: Tuberculosis;   HIV Infections
Interventions: Drug: Rifapentine (RPT);   Drug: Isoniazid (INH);   Dietary Supplement: Pyridoxine (Vitamin B6)
19 Active, not recruiting Connect 'n Unite: Couples-Based HIV/STI Prevention for Drug-Involved, Black MSM
Conditions: HIV;   Sexually Transmitted Infections
Interventions: Behavioral: CNU Intervention;   Behavioral: WP Intervention
20 Completed
Has Results
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
Condition: HIV-1 Infection
Interventions: Drug: EFV/FTC/TDF;   Drug: Calcium Carbonate;   Drug: Vitamin D3;   Drug: Placebo for calcium carbonate;   Drug: Placebo for vitamin D3

   Previous Page Studies Shown (1-20) Next Page (21-29) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.